Article Information
History
- January 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Puya-Dehgani-Mobaraki, President, MD1,
- Chao Wang, PhD, Senior Lecturer in Health & Social Care Statistic2,
- Alessandro Floridi, M.Pharm3,
- Emanuela Floridi, M.D3 and
- Asiya K Zaidi, Research Fellow, MD4,*
- 1Associazione Naso Sano, Umbria Regional Registry of volunteer activities, Italy Via Luca Benincasa 2, San Mariano, 06073, Perugia-Italy
- 2Faculty of Health, Social Care and Education, Kingston University and St George’s, University of London, London, SW17 0RE, UK
- 3Laboratory of Nuclear Lipid BioPathology, Centro Ricerche Analisi Biochimico Specialistiche, Perugia, Italy
- 4Associazione Naso Sano, Italy
- ↵*[Corresponding Author] Asiya Kamber Zaidi, Email: asiyazaidia{at}gmail.com
Posted January 20, 2022.
Long-Term Persistence of IgG Antibodies in recovered COVID-19 individuals at 18 months and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response
